Abstract
Background: Compelling evidence has shown cardiac involvement in COVID-19 patients. However, the overall majority of these studies use data obtained during the first wave of the pandemic, while recently differences have been reported in disease course and mortality between first- and second wave COVID-19 patients. The aim of this study was to analyze and compare cardiac pathology between first- and second wave COVID-19 patients.
Methods: Autopsied hearts from first- (n = 15) and second wave (n = 10) COVID-19 patients and from 18 non-COVID-19 control patients were (immuno)histochemically analyzed. CD45+ leukocyte, CD68+ macrophage and CD3+ T lymphocyte infiltration, cardiomyocyte necrosis and microvascular thrombosis were quantified. In addition, the procoagulant factors Tissue Factor (TF), Factor VII (FVII), Factor XII (FXII), the anticoagulant protein Dipeptidyl Peptidase 4 (DPP4) and the advanced glycation end-product N( ε )-Carboxymethyllysine (CML), as markers of microvascular thrombogenicity and dysfunction, were quantified.
Results: Cardiac inflammation was significantly decreased in second wave compared to first wave COVID-19 patients, predominantly related to a decrease in infiltrated lymphocytes and the occurrence of lymphocytic myocarditis. This was accompanied by significant decreases in cardiomyocyte injury and microvascular thrombosis. Moreover, microvascular deposits of FVII and CML were significantly lower in second wave compared to first wave COVID-19 patients.
Conclusions: These results show that in our cohort of fatal COVID-19 cases cardiac inflammation, cardiomyocyte injury and microvascular thrombogenicity were markedly decreased in second wave compared to first wave patients. This may reflect advances in COVID-19 treatment related to an increased use of steroids in the second COVID-19 wave.
Keywords: COVID-19; First and second wave; Heart; Inflammation; Thrombosis microvasculature.
【저자키워드】 COVID-19, Inflammation, heart, First and second wave, Thrombosis microvasculature., 【초록키워드】 Treatment, Necrosis, Macrophage, pandemic, Mortality, DPP4, Protein, lymphocyte, Cohort, second wave, First wave, patients, COVID-19 patients, Cardiac pathology, marker, Anticoagulant, Evidence, infiltration, cardiac, Injury, COVID-19 patient, leukocyte, factor XII, dysfunction, Microvascular thrombosis, Non-COVID-19, Factor, factor VII, lymphocytic myocarditis, disease course, T lymphocyte, peptidase, significant decrease, fatal COVID-19, significantly lower, CD3+, CML, decrease, CD45+, Occurrence, shown, analyzed, significantly, reported, addition, majority, quantified, accompanied, CD68+, control patient, procoagulant factor, use of steroid, 【제목키워드】 second wave, First wave, change, cardiac, Deceased, COVID-19 patient, procoagulant,